10/02/23 9:00 AMNYSE : BRK, A, B Helzberg Diamonds Introduces New Demi-fine Collection Scout & LarkJewelry industry leader Helzberg Diamonds continues to broaden and expand its assortment to offer customers even more choices for their jewelry wardrobe with the launch of demi-fine jewelry from designer collective Scout& Lark. The new Scout& Lark collection at Helzberg Diamonds is comprised of over 120 items ranging from $79.99 up to $699.99, including a...RHEA-AIneutral
09/27/23 9:20 AMNasdaq : HEXA, B ETQ Updates Cloud-Native Reliance QMS with Customer-Driven Features and FunctionalityETQ, part of Hexagon, has launched a new version of its award-winning ETQ Reliance NXG quality management system. The new features and functionality are designed to boost the user experience for end-users and strengthen the...RHEA-AIvery positive
09/25/23 6:00 AMNasdaq : HEXA, B Hexagon's Sixth Sense Announces Nine Startups to Transform Manufacturing Sustainability and Digital RealityToday, Hexagon's Manufacturing Intelligence division announced the nine manufacturing startups chosen for its third Sixth Sense cohort. Acerta Analytics, Canada: Acerta Analytics provides advanced analytics solutions that leverage machine learning and artificial intelligence to turn complex product data...RHEA-AIpositive
09/25/23 1:46 AMNasdaq : BIOA, B 'LEQEMBI® Intravenous Infusion' approved for the treatment of Alzheimer's disease in JapanBioArctic AB's partner Eisai announced today that "LEQEMBI ® Intravenous Infusion" has been approved in Japan as a treatment for slowing progression of mild cognitive impairment and mild dementia due to Alzheimer's disease. The regulatory approval in Japan announced today, entitles BioArctic to a milestone of EUR 17 M..RHEA-AIneutral
09/22/23 9:00 AMNYSE : B Barnes Aerospace Announces Two Extended Long-Term Agreements with SafranBarnes Aerospace is pleased to announce significant milestones in partnering with Safran Aircraft Engines. The two businesses extended a long-term agreement for the repair and overhaul of components for the highly regarded LEAP and CFM engine programs. Barnes Aerospace performs these repair services for Safran Aircraft Engines in our Singapore and...RHEA-AIvery positive
09/19/23 9:20 AMNasdaq : HEXA, B clinical trialETQ Adds Lotus Clinical Research to Roster of Life Sciences Firms Finding Success with ETQ Reliance Quality Management SystemETQ, part of Hexagon, the leading quality management system provider, is honored to have Lotus Clinical Research, a leading clinical research organization, join its roster of life sciences firms that are gaining advantage and reducing risk with ETQ's Reliance QMS serving as the foundational system for its...RHEA-AIvery positive
09/13/23 9:20 AMNasdaq : HEXA, B ETQ Named "NextGen Digital Transformation Solution Provider" at the 2023 NextGen Solution Provider AwardsETQ, part of Hexagon, the leading quality management system provider, today announced that it was named a Digital Transformation Award recipient, as part of the annual...RHEA-AIvery positive
09/12/23 2:00 PMNYSE : B earningsBarnes Announces Third Quarter 2023 Earnings Conference Call and WebcastBarnes Group Inc. today announced it will release third quarter 2023 financial results on Friday, October 27, 2023, before the market opens. Barnes will also host a conference call which will begin at 8:30 a.m. on that day to discuss the results and the Company’ s outlook. The conference is also available by direct dial at 510-2379 in the U.S. or 960-0691 outside...RHEA-AIneutral
08/31/23 6:30 AMNYSE : B acquisitionBarnes Completes the Acquisition of MB AerospaceBarnes Group Inc. today announced that it has completed its previously announced acquisition of MB Aerospace, a leading provider of precision aero-engine component manufacturing and repair services serving major aerospace and defense engine OEMs, Tier 1 suppliers, and MRO providers. “We’ re excited to welcome MB Aerospace and its talented workforce to...RHEA-AIneutral
08/23/23 5:39 AMNasdaq : BIOA, B BioArctic receives patent in Japan for new antibodies targeting Parkinson's diseaseBioArctic AB announced today that the Japanese Patent Office is granting a new drug substance patent for the antibody BAN0805, invented by BioArctic as a potential treatment of Parkinson's disease. The patent will expire in 2041, with the possibility of a patent term extension up until 2046.. The granted substance patent...RHEA-AIvery positive
